Phage Therapy in the Postantibiotic Era
Open accessThe DOI matches its Crossref record; 172 of the 176 references it cites were found in a registry or an index, and 3 are not checked yet.
Abstract
Antibiotic resistance is arguably the biggest current threat to global health. An increasing number of infections are becoming harder or almost impossible to treat, carrying high morbidity, mortality, and financial cost.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Magiorakos, A.-P., Srinivasan, A., Carey, R. B., Carmeli, Y., Falagas, M. E., Giske, C. G., Harbarth, S., Hindler, J. F., Kahlmeter, G., Olsson-Liljequist, B., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03570.x · Cited by 14,449
Origins and evolution of antibiotic resistance
Davies, J., & Davies, D. (2010) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00016-10 · Cited by 5,784
The antibiotic resistance crisis: part 1: causes and threats.
Ventola, C. L. (2015) · PubMed · Cited by 4,516
Antibiotic resistance is ancient
D’Costa, V. M., King, C. E., Kalan, L., Morar, M., Sung, W. W. L., Schwarz, C., Froese, D., Zazula, G., Calmels, F., Debruyne, R., et al. (2011) · Nature · doi:10.1038/nature10388 · Cited by 2,720
Bacteriophage resistance mechanisms
Labrie, S. J., Samson, J. E., & Moineau, S. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2315 · Cited by 2,397
(2015) · Microbe Magazine · doi:10.1128/microbe.10.354.1 · Cited by 2,266
How antibiotics kill bacteria: from targets to networks
Kohanski, M. A., Dwyer, D. J., & Collins, J. J. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2333 · Cited by 2,258
Nucleotide sequence of bacteriophage G4 DNA
Godson, G. N., Barrell, B. G., Staden, R., & Fiddes, J. C. (1978) · Nature · doi:10.1038/276236a0 · Cited by 2,099
Falagas, M. E., Kasiakou, S. K., & Saravolatz, L. D. (2005) · Clinical Infectious Diseases · doi:10.1086/429323 · Cited by 1,744
A brief history of the antibiotic era: lessons learned and challenges for the future
Aminov, R. I. (2010) · Frontiers in Microbiology · doi:10.3389/fmicb.2010.00134 · Cited by 1,628
Nucleotide sequence of bacteriophage φX174 DNA
Sanger, F., Air, G. M., Barrell, B. G., Brown, N. L., Coulson, A. R., Fiddes, J. C., Hutchison, C. A., Slocombe, P. M., & Smith, M. (1977) · Nature · doi:10.1038/265687a0 · Cited by 1,615
Sampling the Antibiotic Resistome
D'Costa, V. M., McGrann, K. M., Hughes, D. W., & Wright, G. D. (2006) · Science · doi:10.1126/science.1120800 · Cited by 1,594
Sulakvelidze, A., Alavidze, Z., & Morris, J. G. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.3.649-659.2001 · Cited by 1,566
Clinical relevance of the ESKAPE pathogens
Pendleton, J. N., Gorman, S. P., & Gilmore, B. F. (2013) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.13.12 · Cited by 1,423
Resistance to Antibiotics: Are We in the Post-Antibiotic Era?
Alanis, A. J. (2005) · Archives of Medical Research · doi:10.1016/j.arcmed.2005.06.009 · Cited by 1,417
Cosgrove, S. E. (2006) · Clinical Infectious Diseases · doi:10.1086/499406 · Cited by 1,271
Schooley, R. T., Biswas, B., Gill, J. J., Hernandez-Morales, A., Lancaster, J., Lessor, L., Barr, J. J., Reed, S. L., Rohwer, F., Benler, S., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00954-17 · Cited by 1,254
Self-citationSystematic discovery of antiphage defense systems in the microbial pangenome
Doron, S., Melamed, S., Ofir, G., Leavitt, A., Lopatina, A., Keren, M., Amitai, G., & Sorek, R. (2018) · Science · doi:10.1126/science.aar4120 · Cited by 1,250
Clokie, M. R. J., Millard, A. D., Letarov, A. V., & Heaphy, S. (2011) · Bacteriophage · doi:10.4161/bact.1.1.14942 · Cited by 1,149
Phage therapy: An alternative to antibiotics in the age of multi-drug resistance
Lin, D. M., Koskella, B., & Lin, H. C. (2017) · World Journal of Gastrointestinal Pharmacology and Therapeutics · doi:10.4292/wjgpt.v8.i3.162 · Cited by 1,135
Origins and evolution of antibiotic resistance.
DAVIES, J. E. (1996) · PubMed · Cited by 1,033
Pros and cons of phage therapy
Loc-Carrillo, C., & Abedon, S. T. (2011) · Bacteriophage · doi:10.4161/bact.1.2.14590 · Cited by 1,020
A brief history of synthetic biology
Cameron, D. E., Bashor, C. J., & Collins, J. J. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3239 · Cited by 933
Phage Cocktails and the Future of Phage Therapy
Chan, B. K., Abedon, S. T., & Loc-Carrillo, C. (2013) · Future Microbiology · doi:10.2217/fmb.13.47 · Cited by 914
Langdon, A., Crook, N., & Dantas, G. (2016) · Genome Medicine · doi:10.1186/s13073-016-0294-z · Cited by 912
Dispersing biofilms with engineered enzymatic bacteriophage
Lu, T. K., & Collins, J. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704624104 · Cited by 895
Jault, P., Leclerc, T., Jennes, S., Pirnay, J. P., Que, Y.-A., Resch, G., Rousseau, A. F., Ravat, F., Carsin, H., Le Floch, R., et al. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30482-1 · Cited by 874
Wright, A., Hawkins, C. H., Änggård, E. E., & Harper, D. R. (2009) · Clinical Otolaryngology · doi:10.1111/j.1749-4486.2009.01973.x · Cited by 864
Microbiomes in light of traits: a phylogenetic perspective
Martiny, J. B. H., Jones, S. E., Lennon, J. T., & Martiny, A. C. (2015) · Science · doi:10.1126/science.aac9323 · Cited by 834
Host receptors for bacteriophage adsorption
Bertozzi Silva, J., Storms, Z., & Sauvageau, D. (2016) · FEMS Microbiology Letters · doi:10.1093/femsle/fnw002 · Cited by 736
Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa
Chan, B. K., Sistrom, M., Wertz, J. E., Kortright, K. E., Narayan, D., & Turner, P. E. (2016) · Scientific Reports · doi:10.1038/srep26717 · Cited by 715
Ellis, E. L., & Delbrück, M. (1939) · Journal of General Physiology · doi:10.1085/jgp.22.3.365 · Cited by 696
The role of antibiotics and antibiotic resistance in nature
Aminov, R. I. (2009) · Environmental Microbiology · doi:10.1111/j.1462-2920.2009.01972.x · Cited by 687
Phage Therapy in Clinical Practice: Treatment of Human Infections
Kutter, E., De Vos, D., Gvasalia, G., Alavidze, Z., Gogokhia, L., Kuhl, S., & Abedon, S. (2010) · Current Pharmaceutical Biotechnology · doi:10.2174/138920110790725401 · Cited by 670
The Scourge of Antibiotic Resistance: The Important Role of the Environment
Finley, R. L., Collignon, P., Larsson, D. G. J., McEwen, S. A., Li, X.-Z., Gaze, W. H., Reid-Smith, R., Timinouni, M., Graham, D. W., & Topp, E. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit355 · Cited by 636
Better Tests, Better Care: Improved Diagnostics for Infectious Diseases
Caliendo, A. M., Gilbert, D. N., Ginocchio, C. C., Hanson, K. E., May, L., Quinn, T. C., Tenover, F. C., Alland, D., Blaschke, A. J., Bonomo, R. A., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit578 · Cited by 628
Combination approaches to combat multidrug-resistant bacteria
Worthington, R. J., & Melander, C. (2013) · Trends in Biotechnology · doi:10.1016/j.tibtech.2012.12.006 · Cited by 625 · cited 1×
“threat of bacterial resistance, a commonly used strategy is the combination of two or more antibiotics (98) with the hope of achieving a synergistic effect.”
BackgroundAntibiotic Adjuvants: Rescuing Antibiotics from Resistance
Wright, G. D. (2016) · Trends in Microbiology · doi:10.1016/j.tim.2016.06.009 · Cited by 604
Wittebole, X., De Roock, S., & Opal, S. M. (2014) · Virulence · doi:10.4161/viru.25991 · Cited by 599
Bacteriophage therapy: a potential solution for the antibiotic resistance crisis
Golkar, Z., Bagasra, O., & Pace, D. G. (2014) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.3573 · Cited by 593
Importance of prophages to evolution and virulence of bacterial pathogens
Fortier, L.-C., & Sekulovic, O. (2013) · Virulence · doi:10.4161/viru.24498 · Cited by 577
Human Volunteers Receiving Escherichia coli Phage T4 Orally: a Safety Test of Phage Therapy
Bruttin, A., & Brüssow, H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.7.2874-2878.2005 · Cited by 563
Phage-Antibiotic Synergy (PAS): β-Lactam and Quinolone Antibiotics Stimulate Virulent Phage Growth
Comeau, A., Tétart, F., Trojet, S. N., Prère, M. F., & Krisch, H. M. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000799 · Cited by 554
The phage‐host arms race: Shaping the evolution of microbes
Stern, A., & Sorek, R. (2011) · BioEssays · doi:10.1002/bies.201000071 · Cited by 527
Rapid Killing of Streptococcus pneumoniae with a Bacteriophage Cell Wall Hydrolase
Loeffler, J. M., Nelson, D., & Fischetti, V. A. (2001) · Science · doi:10.1126/science.1066869 · Cited by 517
Long-circulating bacteriophage as antibacterial agents.
Merril, C. R., Biswas, B., Carlton, R., Jensen, N. C., Creed, G. J., Zullo, S., & Adhya, S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3188 · Cited by 512
Population and evolutionary dynamics of phage therapy
Levin, B. R., & Bull, J. J. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro822 · Cited by 511
Jordan, T. C., Burnett, S. H., Carson, S., Caruso, S. M., Clase, K., DeJong, R. J., Dennehy, J. J., Denver, D. R., Dunbar, D., Elgin, S. C. R., et al. (2014) · mBio · doi:10.1128/mbio.01051-13 · Cited by 509
Phage treatment of an aortic graft infected with Pseudomonas aeruginosa
Chan, B. K., Turner, P. E., Kim, S., Mojibian, H. R., Elefteriades, J. A., & Narayan, D. (2018) · Evolution, Medicine, and Public Health · doi:10.1093/emph/eoy005 · Cited by 501
Functional metagenomics reveals diverse β-lactamases in a remote Alaskan soil
Allen, H. K., Moe, L. A., Rodbumrer, J., Gaarder, A., & Handelsman, J. (2009) · The ISME Journal · doi:10.1038/ismej.2008.86 · Cited by 500
Bacteria-Phage Antagonistic Coevolution in Soil
Gómez, P., & Buckling, A. (2011) · Science · doi:10.1126/science.1198767 · Cited by 495
Roach, D. R., Leung, C. Y., Henry, M., Morello, E., Singh, D., Di Santo, J. P., Weitz, J. S., & Debarbieux, L. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.06.018 · Cited by 484
Principles of pharmacology : the pathophysiologic basis of drug therapy
Golan, D. E., & Tashjian, A. H. (2012) · Cited by 469
Bacteriophage therapy of venous leg ulcers in humans: results of a phase I safety trial
Rhoads, D. D., Wolcott, R. D., Kuskowski, M. A., Wolcott, B. M., Ward, L. S., & Sulakvelidze, A. (2009) · Journal of Wound Care · doi:10.12968/jowc.2009.18.6.42801 · Cited by 468
Biswas, B., Adhya, S., Washart, P., Paul, B., Trostel, A. N., Powell, B., Carlton, R., & Merril, C. R. (2002) · Infection and Immunity · doi:10.1128/iai.70.1.204-210.2002 · Cited by 467
Leverentz, B., Conway, W. S., Camp, M. J., Janisiewicz, W. J., Abuladze, T., Yang, M., Saftner, R., & Sulakvelidze, A. (2003) · Applied and Environmental Microbiology · doi:10.1128/aem.69.8.4519-4526.2003 · Cited by 445
Smith, H. W., & Huggins, M. B. (1983) · Microbiology · doi:10.1099/00221287-129-8-2659 · Cited by 436
Mechanisms of antibiotic resistance
Munita, J. M., & Arias, C. A. (2016) · Virulence Mechanisms of Bacterial Pathogens · doi:10.1128/9781555819286.ch17 · Cited by 421
Engineered Endolysin-Based “Artilysins” To Combat Multidrug-Resistant Gram-Negative Pathogens
Briers, Y., Walmagh, M., Van Puyenbroeck, V., Cornelissen, A., Cenens, W., Aertsen, A., Oliveira, H., Azeredo, J., Verween, G., Pirnay, J.-P., et al. (2014) · mBio · doi:10.1128/mbio.01379-14 · Cited by 421
Doron, S., & Davidson, L. E. (2011) · Mayo Clinic Proceedings · doi:10.4065/mcp.2011.0358 · Cited by 415
Phage Therapy—History from Twort and d'Herelle Through Soviet Experience to Current Approaches
Chanishvili, N. (2012) · Advances in Virus Research · doi:10.1016/b978-0-12-394438-2.00001-3 · Cited by 407
Virulence Mechanisms of Bacterial Pathogens
(2016) · ASM Press eBooks · doi:10.1128/9781555819286 · Cited by 405
Synergy and Order Effects of Antibiotics and Phages in Killing Pseudomonas aeruginosa Biofilms
Chaudhry, W. N., Concepción-Acevedo, J., Park, T., Andleeb, S., Bull, J. J., & Levin, B. R. (2017) · PLOS ONE · doi:10.1371/journal.pone.0168615 · Cited by 394
The role of vaccines in preventing bacterial antimicrobial resistance
Jansen, K. U., Knirsch, C., & Anderson, A. S. (2018) · Nature Medicine · doi:10.1038/nm.4465 · Cited by 355
Pirnay, J.-P., Verbeken, G., Ceyssens, P.-J., Huys, I., De Vos, D., Ameloot, C., & Fauconnier, A. (2018) · Viruses · doi:10.3390/v10020064 · Cited by 347
"Who discovered bacteriophage?"
Duckworth, D. H. (1976) · Bacteriological Reviews · doi:10.1128/br.40.4.793-802.1976 · Cited by 336
Oechslin, F., Piccardi, P., Mancini, S., Gabard, J., Moreillon, P., Entenza, J. M., Resch, G., & Que, Y.-A. (2016) · Journal of Infectious Diseases · doi:10.1093/infdis/jiw632 · Cited by 325
Evolutionary Rationale for Phages as Complements of Antibiotics
Torres-Barceló, C., & Hochberg, M. E. (2016) · Trends in Microbiology · doi:10.1016/j.tim.2015.12.011 · Cited by 308
Mammalian Host-Versus-Phage immune response determines phage fate in vivo
Hodyra-Stefaniak, K., Miernikiewicz, P., Drapała, J., Drab, M., Jończyk-Matysiak, E., Lecion, D., Kaźmierczak, Z., Beta, W., Majewska, J., Harhala, M., et al. (2015) · Scientific Reports · doi:10.1038/srep14802 · Cited by 302
Simpkin, V. L., Renwick, M. J., Kelly, R., & Mossialos, E. A. (2017) · The Journal of Antibiotics · doi:10.1038/ja.2017.124 · Cited by 299
The Role of Bacterial Polysaccharide Capsules as Virulence Factors
Moxon, E. R., & Kroll, J. S. (1990) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-74694-9_4 · Cited by 287
A new strategy to fight antimicrobial resistance: the revival of old antibiotics
Cassir, N., Rolain, J.-M., & Brouqui, P. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00551 · Cited by 280
Phage lysis: do we have the hole story yet?
Young, R. (2013) · Current Opinion in Microbiology · doi:10.1016/j.mib.2013.08.008 · Cited by 274
Virulence reduction in bacteriophage resistant bacteria
León, M., & Bastías, R. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00343 · Cited by 271
McCallin, S., Alam Sarker, S., Barretto, C., Sultana, S., Berger, B., Huq, S., Krause, L., Bibiloni, R., Schmitt, B., Reuteler, G., et al. (2013) · Virology · doi:10.1016/j.virol.2013.05.022 · Cited by 265
Jennes, S., Merabishvili, M., Soentjens, P., Pang, K. W., Rose, T., Keersebilck, E., Soete, O., François, P.-M., Teodorescu, S., Verween, G., et al. (2017) · Critical Care · doi:10.1186/s13054-017-1709-y · Cited by 248
Viertel, T. M., Ritter, K., & Horz, H.-P. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku173 · Cited by 243
Markoishvili, K., Tsitlanadze, G., Katsarava, R., Glenn, J., Morris Jr., M. D., & Sulakvelidze, A. (2002) · International Journal of Dermatology · doi:10.1046/j.1365-4362.2002.01451.x · Cited by 243
Nale, J. Y., Spencer, J., Hargreaves, K. R., Buckley, A. M., Trzepiński, P., Douce, G. R., & Clokie, M. R. J. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01774-15 · Cited by 243
A century of phage research: Bacteriophages and the shaping of modern biology
Keen, E. C. (2015) · BioEssays · doi:10.1002/bies.201400152 · Cited by 242
Oral T4-like phage cocktail application to healthy adult volunteers from Bangladesh
Sarker, S. A., McCallin, S., Barretto, C., Berger, B., Pittet, A.-C., Sultana, S., Krause, L., Huq, S., Bibiloni, R., Bruttin, A., et al. (2012) · Virology · doi:10.1016/j.virol.2012.09.002 · Cited by 240
Yelin, I., & Kishony, R. (2018) · Cell · doi:10.1016/j.cell.2018.02.018 · Cited by 240
Bacterial viruses enable their host to acquire antibiotic resistance genes from neighbouring cells
Haaber, J., Leisner, J. J., Cohn, M. T., Catalan-Moreno, A., Nielsen, J. B., Westh, H., Penadés, J. R., & Ingmer, H. (2016) · Nature Communications · doi:10.1038/ncomms13333 · Cited by 236
Chibani-Chennoufi, S., Sidoti, J., Bruttin, A., Kutter, E., Sarker, S., & Brüssow, H. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.7.2558-2569.2004 · Cited by 234
Daniel, A., Euler, C., Collin, M., Chahales, P., Gorelick, K. J., & Fischetti, V. A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01625-09 · Cited by 233
Yoong, P., Schuch, R., Nelson, D., & Fischetti, V. A. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.14.4808-4812.2004 · Cited by 233
Cheng, Q., Nelson, D., Zhu, S., & Fischetti, V. A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.1.111-117.2005 · Cited by 233
Phage display as a promising approach for vaccine development
Aghebati-Maleki, L., Bakhshinejad, B., Baradaran, B., Motallebnezhad, M., Aghebati-Maleki, A., Nickho, H., Yousefi, M., & Majidi, J. (2016) · Journal of Biomedical Science · doi:10.1186/s12929-016-0285-9 · Cited by 233
Rashel, M., Uchiyama, J., Ujihara, T., Uehara, Y., Kuramoto, S., Sugihara, S., Yagyu, K., Muraoka, A., Sugai, M., Hiramatsu, K., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/521305 · Cited by 232
Perron, G. G., Whyte, L., Turnbaugh, P. J., Goordial, J., Hanage, W. P., Dantas, G., & Desai, M. M. (2015) · PLOS ONE · doi:10.1371/journal.pone.0069533 · Cited by 229
Kamal, F., & Dennis, J. J. (2015) · Applied and Environmental Microbiology · doi:10.1128/aem.02850-14 · Cited by 224
Maciejewska, B., Olszak, T., & Drulis-Kawa, Z. (2018) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-018-8811-1 · Cited by 222
Treatment of experimental infections of mice with bacteriophages
SOOTHILL, J. S. (1992) · Journal of Medical Microbiology · doi:10.1099/00222615-37-4-258 · Cited by 220
Reversing Bacterial Resistance to Antibiotics by Phage-Mediated Delivery of Dominant Sensitive Genes
Edgar, R., Friedman, N., Molshanski-Mor, S., & Qimron, U. (2012) · Applied and Environmental Microbiology · doi:10.1128/aem.05741-11 · Cited by 217
PlyC: A multimeric bacteriophage lysin
Nelson, D., Schuch, R., Chahales, P., Zhu, S., & Fischetti, V. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604521103 · Cited by 207
van Rijen, M. M. L., Bonten, M., Wenzel, R. P., & Kluytmans, J. A. J. W. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm480 · Cited by 207
Phage therapy—constraints and possibilities
Nilsson, A. S. (2014) · Upsala Journal of Medical Sciences · doi:10.3109/03009734.2014.902878 · Cited by 206
Chhibber, S., Kaur, T., & Kaur, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056022 · Cited by 204
CONDITIONS FOR THE EXISTENCE OF BACTERIOPHAGE
Campbell, A. (1961) · Evolution · doi:10.1111/j.1558-5646.1961.tb03139.x · Cited by 203
Antibiotic peptides from higher eukaryotes: biology and applications
Ganz, T., & Lehrer, R. I. (1999) · Molecular Medicine Today · doi:10.1016/s1357-4310(99)01490-2 · Cited by 197
Park, J. Y., Moon, B. Y., Park, J. W., Thornton, J. A., Park, Y. H., & Seo, K. S. (2017) · Scientific Reports · doi:10.1038/srep44929 · Cited by 195
Chhibber, S., Kaur, S., & Kumari, S. (2008) · Journal of Medical Microbiology · doi:10.1099/jmm.0.2008/002873-0 · Cited by 194
Briers, Y., & Lavigne, R. (2015) · Future Microbiology · doi:10.2217/fmb.15.8 · Cited by 189
Pastagia, M., Euler, C., Chahales, P., Fuentes-Duculan, J., Krueger, J. G., & Fischetti, V. A. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00890-10 · Cited by 188
Jun, S. Y., Jang, I. J., Yoon, S., Jang, K., Yu, K.-S., Cho, J. Y., Seong, M.-W., Jung, G. M., Yoon, S. J., & Kang, S. H. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02629-16 · Cited by 184
Characterizing Phage Genomes for Therapeutic Applications
Philipson, C., Voegtly, L., Lueder, M., Long, K., Rice, G., Frey, K., Biswas, B., Cer, R., Hamilton, T., & Bishop-Lilly, K. (2018) · Viruses · doi:10.3390/v10040188 · Cited by 183
A signal-arrest-release sequence mediates export and control of the phage P1 endolysin
Xu, M., Struck, D. K., Deaton, J., Wang, I.-N., & Young, R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400957101 · Cited by 180
Hall, A. R., De Vos, D., Friman, V.-P., Pirnay, J.-P., & Buckling, A. (2012) · Applied and Environmental Microbiology · doi:10.1128/aem.00757-12 · Cited by 180
The intrinsic resistome of bacterial pathogens
Olivares, J., Bernardini, A., Garcia-Leon, G., Corona, F., B. Sanchez, M., & Martinez, J. L. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00103 · Cited by 177
The Gut Microbiota Facilitates Drifts in the Genetic Diversity and Infectivity of Bacterial Viruses
De Sordi, L., Khanna, V., & Debarbieux, L. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.10.010 · Cited by 169
Torres-Barceló, C., Arias-Sánchez, F. I., Vasse, M., Ramsayer, J., Kaltz, O., & Hochberg, M. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106628 · Cited by 166
Hua, Y., Luo, T., Yang, Y., Dong, D., Wang, R., Wang, Y., Xu, M., Guo, X., Hu, F., & He, P. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02659 · Cited by 166
Adapting Drug Approval Pathways for Bacteriophage-Based Therapeutics
Cooper, C. J., Khan Mirzaei, M., & Nilsson, A. S. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01209 · Cited by 165
Górski, A., Międzybrodzki, R., Weber‐Dąbrowska, B., Fortuna, W., Letkiewicz, S., Rogóż, P., Jończyk‐Matysiak, E., Dąbrowska, K., Majewska, J., & Borysowski, J. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01515 · Cited by 164
Totté, J. E. E., van Doorn, M. B., & Pasmans, S. G. M. A. (2017) · Case Reports in Dermatology · doi:10.1159/000473872 · Cited by 161
Safety and efficacy of phage therapy via the intravenous route
Speck, P., & Smithyman, A. (2016) · FEMS Microbiology Letters · doi:10.1093/femsle/fnv242 · Cited by 160
Phage-antibiotic synergism: a possible approach to combatting Pseudomonas aeruginosa
Knezevic, P., Curcin, S., Aleksic, V., Petrusic, M., & Vlaski, L. (2013) · Research in Microbiology · doi:10.1016/j.resmic.2012.08.008 · Cited by 159
Clostridium difficile phages: still difficult?
Hargreaves, K. R., & Clokie, M. R. J. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00184 · Cited by 156
Targeted Drug-Carrying Bacteriophages as Antibacterial Nanomedicines
Yacoby, I., Bar, H., & Benhar, I. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00163-07 · Cited by 152
Phage therapy of staphylococcal chronic osteomyelitis in experimental animal model
Nath, G., Kishor, C., Mishra, R., Saraf, S., Kumar, M., & Srivastav, A. (2016) · The Indian Journal of Medical Research · doi:10.4103/0971-5916.178615 · Cited by 151
Bacteriophage prehistory: Is or is not Hankin, 1896, a phage reference?
Abedon, S. T., Thomas-Abedon, C., Thomas, A., & Mazure, H. (2011) · Bacteriophage · doi:10.4161/bact.1.3.16591 · Cited by 148
Melo, L. D. R., Veiga, P., Cerca, N., Kropinski, A. M., Almeida, C., Azeredo, J., & Sillankorva, S. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01024 · Cited by 148
Mahichi, F., Synnott, A. J., Yamamichi, K., Osada, T., & Tanji, Y. (2009) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2009.01588.x · Cited by 147
Sarker, S. A., Berger, B. W., Deng, Y., Kieser, S., Foata, F., Moine, D., Descombes, P., Sultana, S., Huq, S., Bardhan, P. K., et al. (2016) · Environmental Microbiology · doi:10.1111/1462-2920.13574 · Cited by 144
Breaking free: “Protein antibiotics” and phage lysis
Bernhardt, T. G., Wang, I., Struck, D. K., & Young, R. (2002) · Research in Microbiology · doi:10.1016/s0923-2508(02)01330-x · Cited by 139
Eaton, M. D., & Bayne‐Jones, S. (1934) · JAMA · doi:10.1001/jama.1934.72750490003007 · Cited by 138
Phage therapy redux—What is to be done?
Young, R., & Gill, J. J. (2015) · Science · doi:10.1126/science.aad6791 · Cited by 129
Kim, K., Cha, J., Jang, E., Klumpp, J., Hagens, S., Hardt, W., Lee, K., & Loessner, M. J. (2008) · Microbial Biotechnology · doi:10.1111/j.1751-7915.2008.00028.x · Cited by 128
Bedi, M.-S., Verma, V., & Chhibber, S. (2009) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-009-9991-8 · Cited by 125
Bacteriophage Therapy ofSalmonella enterica:A Fresh Appraisal of Bacteriophage Therapy
Capparelli, R., Nocerino, N., Iannaccone, M., Ercolini, D., Parlato, M., Medaglia, C., & Iannelli, D. (2009) · The Journal of Infectious Diseases · doi:10.1086/648478 · Cited by 120
Choffnes, E. R., Relman, D. A., & Mack, A. (2010) · Cited by 118
What are the limitations on the wider therapeutic use of phage?
Henein, A. E. (2013) · Bacteriophage · doi:10.4161/bact.24872 · Cited by 118
Population cycles and species diversity in dynamic Kill-the-Winner model of microbial ecosystems
Maslov, S., & Sneppen, K. (2017) · Scientific Reports · doi:10.1038/srep39642 · Cited by 118
Nóbrega, F. L., Costa, A. R., Santos, J. F., Siliakus, M. F., van Lent, J. W. M., Kengen, S. W. M., Azeredo, J., & Kluskens, L. (2016) · Scientific Reports · doi:10.1038/srep39235 · Cited by 117
Molecular Basis for Lytic Bacteriophage Resistance in Enterococci
Duerkop, B. A., Huo, W., Bhardwaj, P., Palmer, K. L., & Hooper, L. V. (2016) · mBio · doi:10.1128/mbio.01304-16 · Cited by 112
Effects of single and combined use of bacteriophages and antibiotics to inactivate Escherichia coli
Valério, N., Oliveira, C., Jesus, V. I. R., Branco, T. M., Pereira, C., Moreirinha, C., & Almeida, A. (2017) · Virus Research · doi:10.1016/j.virusres.2017.07.015 · Cited by 107
Capparelli, R., Nocerino, N., Lanzetta, R., Silipo, A., Amoresano, A., Giangrande, C., Becker, K., Blaiotta, G., Evidente, A., Cimmino, A., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011720 · Cited by 105
Mushtaq, N., Redpath, M. B., Luzio, J. P., & Taylor, P. W. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki177 · Cited by 105
Gindin, M., Febvre, H. P., Rao, S., Wallace, T. C., & Weir, T. L. (2018) · Journal of the American College of Nutrition · doi:10.1080/07315724.2018.1483783 · Cited by 102
Vitiello, C. L., Merril, C. R., & Adhya, S. L. (2005) · Virus Research · doi:10.1016/j.virusres.2005.05.014 · Cited by 101
The truncated phage lysin CHAPkeliminatesStaphylococcusaureusin the nares of mice
Fenton, M., Casey, P. G., Hill, C., Gahan, C. G. M., McAuliffe, O. E., Mahony, J. O., Maher, F., & Coffey, A. (2010) · Bioengineered Bugs · doi:10.4161/bbug.1.6.13422 · Cited by 100
The antibiotic pipeline: reviving research and development and speeding drugs to market
Luepke, K. H., & Mohr, J. (2017) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2017.1308251 · Cited by 98
Kaur, S., Harjai, K., & Chhibber, S. (2012) · Applied and Environmental Microbiology · doi:10.1128/aem.02371-12 · Cited by 95
Bours, P. H. A., Polak, R., Hoepelman, A. I. M., Delgado, E., Jarquin, A. J. M., & Matute, A. J. (2010) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2010.02.2264 · Cited by 90
Information Phage Therapy Research Should Report
Abedon, S. T. (2017) · Pharmaceuticals · doi:10.3390/ph10020043 · Cited by 87
Metagenomic Analysis of Therapeutic PYO Phage Cocktails from 1997 to 2014
Villarroel, J., Larsen, M., Kilstrup, M., & Nielsen, M. (2017) · Viruses · doi:10.3390/v9110328 · Cited by 86
Yang, H., Wang, M., Yu, J., & Wei, H. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.01471 · Cited by 85
Antibiotic Hypersensitivity Reactions and Approaches to Desensitization
Legendre, D. P., Muzny, C. A., Marshall, G. D., & Swiatlo, E. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit949 · Cited by 84
Eugster, M. R., & Loessner, M. J. (2012) · Journal of Bacteriology · doi:10.1128/jb.00808-12 · Cited by 82
The first phage electron micrographs
Ackermann, H.-W. (2011) · Bacteriophage · doi:10.4161/bact.1.4.17280 · Cited by 78
Bacteriophages and Their Derivatives as Biotherapeutic Agents in Disease Prevention and Treatment
Elbreki, M., Ross, R. P., Hill, C., O’Mahony, J., McAuliffe, O. E., & Coffey, A. (2014) · Journal of Viruses · doi:10.1155/2014/382539 · Cited by 75
Jeon, J., Ryu, C., Lee, J.-Y., Park, J., Yong, D., & Lee, K. (2016) · Applied and Environmental Microbiology · doi:10.1128/aem.00526-16 · Cited by 74
Born, Y., Fieseler, L., Klumpp, J., Eugster, M. R., Zurfluh, K., Duffy, B., & Loessner, M. J. (2013) · Environmental Microbiology · doi:10.1111/1462-2920.12212 · Cited by 73
Genetic and Biochemical Analysis of Dimer and Oligomer Interactions of the λ S Holin
Gründling, A., Bläsi, U., & Young, R. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.21.6082-6090.2000 · Cited by 72
Silk route to the acceptance and re‐implementation of bacteriophage therapy
therapy, E. R. T. O. A. A. R. O. B. (2016) · Biotechnology Journal · doi:10.1002/biot.201600023 · Cited by 72
Effectiveness of bacteriophages in the sputum of cystic fibrosis patients
Saussereau, E., Vachier, I., Chiron, R., Godbert, B., Sermet‐Gaudelus, I., Dufour, N., Pirnay, J., Vos, D. D., Carrié, F., Molinari, N., et al. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12712 · Cited by 68
Eaton, M. D., & Bayne‐Jones, S. (1934) · JAMA · doi:10.1001/jama.1934.72750510005009 · Cited by 67
Slopek, S., Kucharewicz-Krukowska, A., Weber‐Dąbrowska, B., & Dabrowski, M. (1985) · PubMed · Cited by 64
Age, Homocysteine, and Oxidative Stress: Relation to Hypertension and Type 2 Diabetes Mellitus
Dominguez, L. J., Galioto, A., Pineo, A., Ferlisi, A., Ciaccio, M., Putignano, E., Belvedere, M., Costanza, G., & Barbagallo, M. (2010) · Journal of the American College of Nutrition · doi:10.1080/07315724.2010.10719810 · Cited by 63
Rohwer, F. L., & Segall, A. M. (2015) · Nature · doi:10.1038/528046a · Cited by 60
Totté, J. E. E., de Wit, J., Pardo, L. M., Schuren, F. H. J., van Doorn, M. B. A., & Pasmans, S. G. M. A. (2017) · Trials · doi:10.1186/s13063-017-2118-x · Cited by 60
Institute of Medicine (2010) · National Academies Press eBooks · doi:10.17226/12925 · Cited by 60
TWO-STEP RESISTANCE BY ESCHERICHIA COLI B TO BACTERIOPHAGE T2
Lenski, R. E. (1984) · Genetics · doi:10.1093/genetics/107.1.1 · Cited by 56
Moradpour, Z., Sepehrizadeh, Z., Rahbarizadeh, F., Ghasemian, A., Yazdi, M. T., & Shahverdi, A. R. (2009) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2009.01620.x · Cited by 52
Jun, S. Y., Jung, G. M., Yoon, S. J., Youm, S. Y., Han, H., Lee, J., & Kang, S. H. (2016) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12613 · Cited by 49
Evans, T. J., Trauner, A., Komitopoulou, E., & Salmond, G. P. C. (2009) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2009.04462.x · Cited by 48
Silencing of Antibiotic Resistance in E. coli with Engineered Phage Bearing Small Regulatory RNAs
Libis, V. K., Bernheim, A. G., Basier, C., Jaramillo-Riveri, S., Deyell, M., Aghoghogbe, I., Atanasković, I., Bencherif, A. C., Benony, M., Krink, N., et al. (2014) · ACS Synthetic Biology · doi:10.1021/sb500033d · Cited by 45
Bacteriophage-based tools: recent advances and novel applications
O’Sullivan, L., Buttimer, C., McAuliffe, O. E., Bolton, D., & Coffey, A. (2016) · F1000Research · doi:10.12688/f1000research.9705.1 · Cited by 43
P1 Ref Endonuclease: A Molecular Mechanism for Phage-Enhanced Antibiotic Lethality
Ronayne, E. A., Wan, Y. C. S., Boudreau, B. A., Landick, R. C., & Cox, M. M. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1005797 · Cited by 40
Dong, S., Shi, H., Zhang, X., Chen, X., Cao, D., Mao, C., Gao, X., & Wang, L. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s156815 · Cited by 37
Eaton, M. D., & Bayne‐Jones, S. (1934) · JAMA · doi:10.1001/jama.1934.72750500003009 · Cited by 33
Khan, N. U., Shakeel, N., Makda, A., Mallick, A. S., Memon, M. A., Hashmi, S., Khan, U. R., & Razzak, J. (2013) · QJM · doi:10.1093/qjmed/hct179 · Cited by 30
Hope, C. K., Packer, S., Wilson, M., & Nair, S. P. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp157 · Cited by 28
Knobler, S., Burroughs, T. E., Mahmoud, A. A. F., & Lemon, S. M. (2006) · Cited by 24
Community-Acquired Pneumonia with Risk for Drug-Resistant Pathogens
Fleming, V. H., Buck, B. H., Nix, N. M., Kumar, P., & Southwood, R. L. (2013) · Southern Medical Journal · doi:10.1097/smj.0b013e318287fe71 · Cited by 9
Research works printed but not linked: 6
- Price LB, Newland J, Bole A, Bortolaia V, Larsen J, Loneragan GH, Roach S, Smith TC, So AD, Tollefson L, Wagenaar J, Zaoutis T. 2017. Combating antibiotic resistance—a policy roadmap to reduce use of medically important antibiotics in livestock. George Washington University, Washington, DC.
- World Health Organization. 2017. Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. WHO Press, Geneva, Switzerland.
- World Health Organization. 2014. Antimicrobial resistance: global report on surveillance 2014. WHO Press, Geneva, Switzerland.
- The Review on Antimicrobial Resistance chaired by Jim O’Neill. 2014. Antimicrobial resistance: tackling a crisis for the health and wealth of nations. http://www.jpiamr.eu/wp-content/uploads/2014/12/AMR-Review-Paper-Tackling-a-crisis-for-the-health-and-wealth-of-nations_1-2.pdf.
- World Health Organization 2015. Global action plan on antimicrobial resistance. WHO Press, Geneva, Switzerland.
- Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria 2017. Recommendations for incentivizing the development of vaccines, diagnostics and therapeutics to combat antibiotic resistance. US Department of Health and Human Services, Washington, DC.
Cited by
Antibiotic resistance in microbes: History, mechanisms, therapeutic strategies and future prospects
Uddin, T. M., Chakraborty, A. J., Khusro, A., Zidan, B. R. M., Mitra, S., Emran, T. B., Dhama, K., Ripon, M. K. H., Gajdács, M., Sahibzada, M. U. K., et al. (2021) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2021.10.020 · Cited by 1,311
Antibiotic resistance genes in bacteria: Occurrence, spread, and control
Jian, Z., Zeng, L., Xu, T., Sun, S., Yan, S., Yang, L., Huang, Y., Jia, J., & Dou, T. (2021) · Journal of Basic Microbiology · doi:10.1002/jobm.202100201 · Cited by 416
Bacteriophage-resistant Acinetobacter baumannii are resensitized to antimicrobials
Gordillo Altamirano, F., Forsyth, J. H., Patwa, R., Kostoulias, X., Trim, M., Subedi, D., Archer, S. K., Morris, F. C., Oliveira, C., Kielty, L., et al. (2021) · Nature Microbiology · doi:10.1038/s41564-020-00830-7 · Cited by 349
Self-citationCurrent challenges and future opportunities of phage therapy
Pires, D. P., Costa, A. R., Pinto, G., Meneses, L., & Azeredo, J. (2020) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuaa017 · Cited by 340
Vibrio and major commercially important vibriosis diseases in decapod crustaceans
de Souza Valente, C., & Wan, A. H. L. (2021) · Journal of Invertebrate Pathology · doi:10.1016/j.jip.2020.107527 · Cited by 331
Metadata
- Authors
- Gordillo Altamirano, F. L., & Barr, J. J.
- Affiliations
- School of Biological Sciences, Monash University, Clayton, Victoria, Australia
- Monash University (AU)
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2019-03-20
- Volume
- 32
- Issue
- 2
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- PMC
- PMC6431132
- OpenAlex
- W2910246763
- Cited by
- 1,180
- References
- 176
- Citations by year
- 2026: 245 · 2025: 194 · 2024: 169 · 2023: 157 · 2022: 154 · 2021: 142 · 2020: 86 · 2019: 32
- FWCI
- 11.06
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Clinical Microbiology Reviews (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion)
- Funders
- Department of Education and Training | Australian Research Council (DE170100525)
- National Health and Medical Research Council (NHMRC: 1156588)
- Perpetual Trustees Australia (2018HIG00007)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › Bacteriophages and microbial interactions
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Keywords
- phage therapy, bacteriophages, antibiotic resistance, phage-bacteria interactions, phage-antibiotic combination, phage resistance mechanisms, public outreach
- MeSH terms
- Phage Therapy, Animals, Bacterial Infections, Clinical Trials as Topic, Drug Resistance, Microbial, Humans, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.